Crude odds ratio estimates remained within the range of 1.5–2.0 and 2.0–2.5 range for LTA4H and HGF, respectively, when stratifying for time to death from first symptom onset, time-to-event, ECG classification, chronic coronary syndrome medication, and diabetes status (Figure S2 in the Supplementary Materials). The gene discussed is LTA4H; the disease is diabetes mellitus.